Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 9696028)

Published in Hepatology on August 01, 1998

Authors

J S Markowitz1, P Martin, A J Conrad, J F Markmann, P Seu, H Yersiz, J A Goss, P Schmidt, A Pakrasi, L Artinian, N G Murray, D K Imagawa, C Holt, L I Goldstein, R Stribling, R W Busuttil

Author Affiliations

1: The Dumont-UCLA Transplant Center and the Division of Liver and Pancreas Transplantation, UCLA Medical Center, Los Angeles, CA 90095, USA.

Articles citing this

Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol (2000) 3.26

KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol (2012) 2.10

Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73

KASL clinical practice guidelines: management of chronic hepatitis B. Clin Mol Hepatol (2016) 1.07

Liver transplantation in the UK. World J Gastroenterol (2001) 1.02

New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg (2002) 0.91

Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg (2001) 0.89

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis. Hepatol Int (2011) 0.87

Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin. Dig Dis Sci (2007) 0.86

Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation? J Gastroenterol (2013) 0.86

Update on chronic viral hepatitis. Postgrad Med J (2001) 0.83

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation. BMC Gastroenterol (2010) 0.82

Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin North Am (2010) 0.82

Management of HBV Infection in Liver Transplantation Patients. Int J Med Sci (2005) 0.81

Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B. J Clin Exp Hepatol (2013) 0.81

Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin. Hepat Mon (2011) 0.81

Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues. Ann Clin Microbiol Antimicrob (2006) 0.81

Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts. J Gastroenterol (2010) 0.80

Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol (2010) 0.80

Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro. J Gen Virol (2009) 0.80

Safe and cost-effective control of post-transplantation recurrence of hepatitis B. Hepatol Res (2014) 0.79

The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation. Langenbecks Arch Surg (2011) 0.79

Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome. World J Gastroenterol (2014) 0.79

Hepatitis B recurrence after liver transplantation: a single center experiences and review the literature. Hepat Mon (2013) 0.79

Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol (2009) 0.78

Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation. PLoS One (2012) 0.78

Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease. J Immunol Res (2014) 0.78

One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantation. Can J Gastroenterol Hepatol (2013) 0.77

Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77

Recent advances in prevention of hepatitis B recurrence after liver transplantation. World J Gastroenterol (2015) 0.77

Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study. World J Gastroenterol (2015) 0.76

Contradictory immune response in post liver transplantation hepatitis B and C. Int J Inflam (2014) 0.76

Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate. Liver Transpl (2016) 0.76

Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration. Eur J Clin Pharmacol (2006) 0.76

Hepatitis B immune globulin in liver transplantation prophylaxis: an update. Hepat Mon (2012) 0.76

Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol (2015) 0.76

Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence. Int J Mol Sci (2015) 0.76

Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease. World J Gastroenterol (2006) 0.76

Liver transplantation for hepatitis B virus: Decreasing indication and changing trends. World J Gastroenterol (2015) 0.76

Therapy of Delta Hepatitis. Cold Spring Harb Perspect Med (2015) 0.76

Living donor liver transplantation for patients with alcoholic liver disease. Korean J Hepatobiliary Pancreat Surg (2013) 0.75

Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin. Transplantation (2015) 0.75

Hepatitis B virus infection in liver transplant candidates and recipients. MedGenMed (2005) 0.75

Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience. Int J Clin Exp Pathol (2014) 0.75

Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation. J Clin Transl Hepatol (2016) 0.75

Management of hepatitis B virus infection after liver transplantation. World J Gastroenterol (2015) 0.75

Prophylaxis of hepatitis B infection in solid organ transplant recipients. Therap Adv Gastroenterol (2013) 0.75

Prophylactic managements of hepatitis B viral infection in liver transplantation. World J Gastroenterol (2016) 0.75

Simple nucleos(t)ides as HBV prophylaxis regime of post-liver transplantation: Six-year followed up. World J Hepatol (2010) 0.75

Long term outcome of liver transplantation for viral hepatitis: is there a need to re-evaluate patient selection? Gut (1999) 0.75

Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores. Surg Today (2013) 0.75

The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients. J Gastroenterol (2016) 0.75

[4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009]. Wien Klin Wochenschr (2010) 0.75

Articles by these authors

1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

The repair of double-strand breaks in the nuclear DNA of Saccharomyces cerevisiae and its genetic control. Mol Gen Genet (1976) 6.89

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol (2000) 6.04

Effect of Gibberellin on Germination of Lettuce Seed. Science (1957) 5.27

Nucleotide sequence of the tetM tetracycline resistance determinant of the streptococcal conjugative shuttle transposon Tn1545. Nucleic Acids Res (1986) 4.47

HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science (1982) 4.07

Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg (1994) 3.83

Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg (1984) 3.65

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med (1989) 3.45

Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry (1995) 3.30

An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1. Nat Med (1999) 3.27

Amanita poisoning: treatment and the role of liver transplantation. Am J Med (1989) 3.20

A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J Biomol NMR (1994) 3.16

Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell (2001) 3.05

Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg (1999) 2.79

Dynamic actin-based epithelial adhesion and cell matching during Drosophila dorsal closure. Curr Biol (2000) 2.78

X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71

Mechanisms of epithelial fusion and repair. Nat Cell Biol (2001) 2.63

Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Differentiation (1997) 2.58

Failure of silicone gel breast implants: analysis of literature data for 1652 explanted prostheses. Plast Reconstr Surg (1997) 2.56

Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon. EMBO J (1984) 2.55

Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42

Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40

Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients. Aliment Pharmacol Ther (2013) 2.38

Growth-cone attraction to netrin-1 is converted to repulsion by laminin-1. Nature (1999) 2.37

Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature (1995) 2.33

Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest (1999) 2.29

Perforation of the gallbladder: a frequently mismanaged condition. Am J Surg (1979) 2.26

Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science (1990) 2.25

Safeguards for research using large scale DNA collections. BMJ (2000) 2.22

env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol (2000) 2.17

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16

An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissues. Med Mycol (2001) 2.16

Meta-analysis of observational studies: hepatitis C and survival after renal transplant. J Viral Hepat (2013) 2.15

Putting ion channels to work: mechanoelectrical transduction, adaptation, and amplification by hair cells. Proc Natl Acad Sci U S A (2000) 2.15

Sequencing the erbA gene of avian erythroblastosis virus reveals a new type of oncogene. Science (1984) 2.12

Healing of incisional wounds in the embryonic chick wing bud: characterization of the actin purse-string and demonstration of a requirement for Rho activation. J Cell Biol (1996) 2.12

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09

Major psychological disorders in chronic TMD patients: implications for successful management. J Am Dent Assoc (1992) 2.09

Failure of providers to vaccinate HIV-infected men against hepatitis B: a missed opportunity. Am J Gastroenterol (1993) 2.04

Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood (2001) 2.04

Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg (1995) 2.03

Shipment of human islets for transplantation. Am J Transplant (2007) 2.01

Treatment of necrotizing soft tissue infections. The need for a new approach. Am J Surg (1985) 1.97

Hypodontia due to ectodermal dysplasia: rehabilitation with very early dental implants. Rev Stomatol Chir Maxillofac Chir Orale (2013) 1.97

[Hypodontia due to ectodermal dysplasia: rehabilitation with very early dental implants]. Rev Stomatol Chir Maxillofac Chir Orale (2013) 1.97

The yeast NuA4 and Drosophila MSL complexes contain homologous subunits important for transcription regulation. J Biol Chem (2000) 1.92

Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci (2000) 1.92

Long-term survival after retransplantation of the liver. Ann Surg (1997) 1.91

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol (1997) 1.91

Free energy change of ATP-hydrolysis: a causal factor of early hypoxic failure of the myocardium? J Mol Cell Cardiol (1982) 1.90

Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol (1989) 1.87

Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant (2010) 1.84

The first 100 liver transplants at UCLA. Ann Surg (1987) 1.84

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther (2003) 1.82

Identification of grandchildless loci whose products are required for normal germ-line development in the nematode Caenorhabditis elegans. Genetics (1991) 1.81

Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor. J Cell Physiol (1978) 1.79

Ischemia and reperfusion injury in liver transplantation. Transplant Proc (2005) 1.77

Validation of a model of colon cancer progression. J Pathol (2000) 1.76

Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74

99mTc-tagged chicken liver as a marker of solid food in the human stomach. Am J Dig Dis (1976) 1.74

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73

Heat-stable antifreeze protein from grass. Nature (2000) 1.73

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene (2012) 1.73

Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens (1996) 1.73

Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71

Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant (2011) 1.71

Infections in liver transplant recipients. Clin Infect Dis (1995) 1.71

Sea urchin (lytechinus pictus) late-stage histone H3 and H4 genes: characterization and mapping of a clustered but nontandemly linked multigene family. Cell (1982) 1.69

Role of sympathectomy for hyperhidrosis. Br Med J (1971) 1.68

Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med (2001) 1.67

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol (1995) 1.66

Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol (1995) 1.65

Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1999) 1.63

Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation (1995) 1.63

Sinonasal and sino-orbital aspergillosis in 23 cats: aetiology, clinicopathological features and treatment outcomes. Vet J (2011) 1.63

A dihydroxyboryl-substituted methacrylic polymer for the column chromatographic separation of mononucleotides, oligonucleotides, and transfer ribonucleic acid. Biochemistry (1973) 1.62

Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am J Med (1996) 1.62

General practice patients on long-term psychotropic drugs. A controlled investigation. Br J Psychiatry (1988) 1.62

Depression and substance use in minority middle-school students. Am J Public Health (2001) 1.61

The role of liver biopsy in evaluating acute allograft dysfunction following liver transplantation: a clinical histologic correlation of 34 liver transplants. Hum Pathol (1988) 1.60

Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg (1998) 1.59

Current treatment modalities for hepatocellular carcinoma. Ann Surg (1994) 1.59